Author:
Mendez Natalie,Herrera Vanessa,Zhang Lingzhi,Hedjran Farah,Feuer Ralph,Blair Sarah L.,Trogler William C.,Reid Tony R.,Kummel Andrew C.
Funder
National Institute of Health
NSF Alliance for Graduate Education and the Professoriate
NCI Comprehensive Partnerships to Reduce Cancer Health Disparities
Subject
Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering
Reference55 articles.
1. Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval;Breitbach;Cytokine Growth Factor Rev,2010
2. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy;Heise;Cancer Res,1999
3. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?;Kirn;Gene Ther,2001
4. Current issues and future directions of oncolytic adenoviruses;Yamamoto;Mol Ther,2010
5. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma;Hecht;Clin Cancer Res,2003
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献